Pfizer · Operating Cash Flow (Statement)

Latest reported$13.40Bperiod endingJun 28, 2026

PFE Cash from Operations ($655.80M → $13.40B)

Annual operating cash flow (statement)

High-resolution chart · PNG

PFE operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	11,705,000,000
Dec 31, 2024	12,744,000,000
Dec 31, 2023	8,700,000,000
Dec 31, 2022	29,267,000,000
Dec 31, 2021	32,580,000,000
Dec 31, 2020	14,403,000,000
Dec 31, 2019	12,588,000,000
Dec 31, 2018	15,827,000,000
Dec 31, 2017	16,470,000,000
Dec 31, 2016	15,901,000,000
Dec 31, 2015	14,512,000,000
Dec 31, 2014	16,883,000,000
Dec 31, 2013	17,765,000,000
Dec 31, 2012	17,054,000,000
Dec 31, 2011	20,240,000,000
Dec 31, 2010	11,454,000,000
Dec 31, 2009	16,587,000,000
Dec 31, 2008	18,238,000,000
Dec 31, 2007	13,353,000,000
Dec 31, 2006	17,594,000,000
Dec 31, 2005	14,733,000,000
Dec 31, 2004	16,340,000,000
Dec 31, 2003	11,739,000,000
Dec 31, 2002	10,183,000,000
Dec 31, 2001	9,263,000,000
Dec 31, 2000	6,195,000,000
Dec 31, 1999	3,056,000,000
Dec 31, 1998	2,929,000,000
Dec 31, 1997	1,629,000,000
Dec 31, 1996	2,067,000,000
Dec 31, 1995	1,821,400,000
Dec 31, 1994	1,488,500,000
Dec 31, 1993	1,263,000,000
Dec 31, 1992	807,000,000
Dec 31, 1991	847,600,000
Dec 31, 1990	860,500,000
Dec 31, 1989	655,800,000